214 related articles for article (PubMed ID: 26990635)
1. Human adipose tissue-derived stromal cells can differentiate into megakaryocytes and platelets by secreting endogenous thrombopoietin.
Ono-Uruga Y; Tozawa K; Horiuchi T; Murata M; Okamoto S; Ikeda Y; Suda T; Matsubara Y
J Thromb Haemost; 2016 Jun; 14(6):1285-97. PubMed ID: 26990635
[TBL] [Abstract][Full Text] [Related]
2. OP9 bone marrow stroma cells differentiate into megakaryocytes and platelets.
Matsubara Y; Ono Y; Suzuki H; Arai F; Suda T; Murata M; Ikeda Y
PLoS One; 2013; 8(3):e58123. PubMed ID: 23469264
[TBL] [Abstract][Full Text] [Related]
3. Platelet production using adipose-derived mesenchymal stem cells: Mechanistic studies and clinical application.
Ono-Uruga Y; Ikeda Y; Matsubara Y
J Thromb Haemost; 2021 Feb; 19(2):342-350. PubMed ID: 33217130
[TBL] [Abstract][Full Text] [Related]
4. Human endometrial stromal stem cells differentiate into megakaryocytes with the ability to produce functional platelets.
Wang J; Chen S; Zhang C; Stegeman S; Pfaff-Amesse T; Zhang Y; Zhang W; Amesse L; Chen Y
PLoS One; 2012; 7(8):e44300. PubMed ID: 22952951
[TBL] [Abstract][Full Text] [Related]
5. Long-term platelet production assessed in NOD/SCID mice injected with cord blood CD34+ cells, thrombopoietin-amplified in clinical grade serum-free culture.
Mattia G; Milazzo L; Vulcano F; Pascuccio M; Macioce G; Hassan HJ; Giampaolo A
Exp Hematol; 2008 Feb; 36(2):244-52. PubMed ID: 18023520
[TBL] [Abstract][Full Text] [Related]
6. Preferential ex vivo expansion of megakaryocytes from human cord blood CD34+-enriched cells in the presence of thrombopoietin and limiting amounts of stem cell factor and Flt-3 ligand.
Proulx C; Boyer L; Hurnanen DR; Lemieux R
J Hematother Stem Cell Res; 2003 Apr; 12(2):179-88. PubMed ID: 12804177
[TBL] [Abstract][Full Text] [Related]
7. Induction of functional platelets from mouse and human fibroblasts by p45NF-E2/Maf.
Ono Y; Wang Y; Suzuki H; Okamoto S; Ikeda Y; Murata M; Poncz M; Matsubara Y
Blood; 2012 Nov; 120(18):3812-21. PubMed ID: 22855609
[TBL] [Abstract][Full Text] [Related]
8. GSK-3β negatively regulates megakaryocyte differentiation and platelet production from primary human bone marrow cells in vitro.
Ono M; Matsubara Y; Shibano T; Ikeda Y; Murata M
Platelets; 2011; 22(3):196-203. PubMed ID: 21231855
[TBL] [Abstract][Full Text] [Related]
9. Regulation of platelet lifespan in the presence and absence of thrombopoietin signaling.
Lebois M; Dowling MR; Gangatirkar P; Hodgkin PD; Kile BT; Alexander WS; Josefsson EC
J Thromb Haemost; 2016 Sep; 14(9):1882-7. PubMed ID: 27344013
[TBL] [Abstract][Full Text] [Related]
10. Compared effects of Mpl ligand and other cytokines on human MK differentiation.
Vitrat N; Cohen-Solal K; Norol F; Guichard J; Cramer E; Vainchenker W; Wendling F; Debili N
Stem Cells; 1998; 16 Suppl 2():37-51. PubMed ID: 11012176
[TBL] [Abstract][Full Text] [Related]
11. [Megakaryopoiesis: regulation of platelet production by thrombopoietin].
Vainchenker W; Besancenot R; Favale F
Bull Acad Natl Med; 2013 Feb; 197(2):395-406. PubMed ID: 24919369
[TBL] [Abstract][Full Text] [Related]
12. Ex Vivo Manufacture of Megakaryocytes and Platelets from Stem Cells: Recent Advances Toward Transfusion in Humans.
Catelli LF; Saad STO
Stem Cells Dev; 2021 Apr; 30(7):351-362. PubMed ID: 33622080
[TBL] [Abstract][Full Text] [Related]
13. Advances in megakaryocytopoiesis and thrombopoiesis: from bench to bedside.
Deutsch VR; Tomer A
Br J Haematol; 2013 Jun; 161(6):778-93. PubMed ID: 23594368
[TBL] [Abstract][Full Text] [Related]
14. Milestones in understanding platelet production: a historical overview.
Kuter DJ
Br J Haematol; 2014 Apr; 165(2):248-58. PubMed ID: 24528208
[TBL] [Abstract][Full Text] [Related]
15. Megakaryocytes and platelets from a novel human adipose tissue-derived mesenchymal stem cell line.
Tozawa K; Ono-Uruga Y; Yazawa M; Mori T; Murata M; Okamoto S; Ikeda Y; Matsubara Y
Blood; 2019 Feb; 133(7):633-643. PubMed ID: 30487128
[TBL] [Abstract][Full Text] [Related]
16. Mpl expression on megakaryocytes and platelets is dispensable for thrombopoiesis but essential to prevent myeloproliferation.
Ng AP; Kauppi M; Metcalf D; Hyland CD; Josefsson EC; Lebois M; Zhang JG; Baldwin TM; Di Rago L; Hilton DJ; Alexander WS
Proc Natl Acad Sci U S A; 2014 Apr; 111(16):5884-9. PubMed ID: 24711413
[TBL] [Abstract][Full Text] [Related]
17. Ex vivo expansion of megakaryocyte progenitor cells: cord blood versus mobilized peripheral blood.
De Bruyn C; Delforge A; Martiat P; Bron D
Stem Cells Dev; 2005 Aug; 14(4):415-24. PubMed ID: 16137231
[TBL] [Abstract][Full Text] [Related]
18. Normal platelets and megakaryocytes are produced in vivo in the absence of thrombopoietin.
Bunting S; Widmer R; Lipari T; Rangell L; Steinmetz H; Carver-Moore K; Moore MW; Keller GA; de Sauvage FJ
Blood; 1997 Nov; 90(9):3423-9. PubMed ID: 9345025
[TBL] [Abstract][Full Text] [Related]
19. In vitro large scale production of megakaryocytes to functional platelets from human hematopoietic stem cells.
Kumar PS; Chandrasekhar C; Srikanth L; Sarma PVGK
Biochem Biophys Res Commun; 2018 Oct; 505(1):168-175. PubMed ID: 30243726
[TBL] [Abstract][Full Text] [Related]
20. Changes in endogenous TPO levels during mobilization chemotherapy are predictive of CD34+ megakaryocyte progenitor yield and identify patients at risk of delayed platelet engraftment post-PBPC transplant.
Maharaj D; Steinberg JP; Gouvea JV; Gieser PW
Bone Marrow Transplant; 1999 Mar; 23(6):539-48. PubMed ID: 10217183
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
